Michael Wiederhorn
Stock Analyst at Oppenheimer
(4.00)
# 673
Out of 4,413 analysts
74
Total ratings
60.19%
Success rate
6.81%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Maintains: Outperform | $110 | $72.25 | +52.25% | 6 | Apr 29, 2024 | |
| TDOC Teladoc Health | Maintains: Outperform | $26 → $21 | $12.81 | +63.93% | 9 | Apr 26, 2024 | |
| HUM Humana | Maintains: Outperform | $415 → $370 | $314.21 | +17.76% | 8 | Apr 25, 2024 | |
| CYH Community Health Systems | Maintains: Outperform | $5.5 → $4.5 | $3.44 | +30.81% | 5 | Apr 25, 2024 | |
| ADUS Addus HomeCare | Maintains: Outperform | $118 | $98.40 | +19.92% | 7 | Mar 26, 2024 | |
| EHAB Enhabit | Maintains: Perform | n/a | $10.18 | - | 2 | Mar 7, 2024 | |
| PNTG The Pennant Group | Maintains: Outperform | $18 → $22 | $21.26 | +3.48% | 4 | Mar 1, 2024 | |
| CHE Chemed | Maintains: Outperform | $625 → $650 | $566.10 | +14.82% | 6 | Feb 29, 2024 | |
| ENSG The Ensign Group | Maintains: Outperform | $127 → $130 | $119.45 | +8.83% | 4 | Feb 2, 2024 | |
| UNH UnitedHealth Group | Reiterates: Outperform | $610 | $484.11 | +26.00% | 10 | Jan 17, 2024 | |
| HCA HCA Healthcare | Reiterates: Outperform | $315 | $309.44 | +1.80% | 6 | Jan 17, 2024 | |
| CI Cigna | Reiterates: Outperform | $360 | $357.18 | +0.79% | 3 | Jan 17, 2024 | |
| AMED Amedisys | Maintains: Outperform | $175 → $145 | $91.89 | +57.80% | 4 | Oct 28, 2022 |
Centene
Apr 29, 2024
Maintains: Outperform
Price Target: $110
Current: $72.25
Upside: +52.25%
Teladoc Health
Apr 26, 2024
Maintains: Outperform
Price Target: $26 → $21
Current: $12.81
Upside: +63.93%
Humana
Apr 25, 2024
Maintains: Outperform
Price Target: $415 → $370
Current: $314.21
Upside: +17.76%
Community Health Systems
Apr 25, 2024
Maintains: Outperform
Price Target: $5.5 → $4.5
Current: $3.44
Upside: +30.81%
Addus HomeCare
Mar 26, 2024
Maintains: Outperform
Price Target: $118
Current: $98.40
Upside: +19.92%
Enhabit
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $10.18
Upside: -
The Pennant Group
Mar 1, 2024
Maintains: Outperform
Price Target: $18 → $22
Current: $21.26
Upside: +3.48%
Chemed
Feb 29, 2024
Maintains: Outperform
Price Target: $625 → $650
Current: $566.10
Upside: +14.82%
The Ensign Group
Feb 2, 2024
Maintains: Outperform
Price Target: $127 → $130
Current: $119.45
Upside: +8.83%
UnitedHealth Group
Jan 17, 2024
Reiterates: Outperform
Price Target: $610
Current: $484.11
Upside: +26.00%
HCA Healthcare
Jan 17, 2024
Reiterates: Outperform
Price Target: $315
Current: $309.44
Upside: +1.80%
Cigna
Jan 17, 2024
Reiterates: Outperform
Price Target: $360
Current: $357.18
Upside: +0.79%
Amedisys
Oct 28, 2022
Maintains: Outperform
Price Target: $175 → $145
Current: $91.89
Upside: +57.80%